A Study to Compare Oral Absorption of YM060 Between Orally-disintegrating Tablet and Conventional Tablet Under With Water Intake
NCT01394653
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Plasma Concentration of YM060
Interventions
DRUG:
YM060
Sponsor
Astellas Pharma Inc